Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
£500 Million Saving Anually by More Accurate Use of Antibiotics
Thursday, August 07, 2014
Study reveals that the proportion of patients given antibiotics for coughs and colds has risen by a staggering 40% this century

Analytik Jena Launches New Generation of Thermal Cyclers
Tuesday, August 05, 2014
TAdvanced from Analytik Jena gives excellent heating and cooling rates.

Insight Genetics Adds Six New Team Members
Monday, August 04, 2014
Growing molecular diagnostic company expands expertise in research, development and quality assurance.

MedMira Expands Multiplo Product Range with Three New Rapid Vertical Flow Tests
Monday, August 04, 2014
MedMira, Inc. is expanding its Multiplo product line with the addition of three new multiplex tests that deliver instant, simultaneous, single-cartridge results for syphilis (TP), HIV, and hepatitis C.

Siemens Showcases New Workflow, Testing and Training Solutions
Thursday, July 31, 2014
Company unveils its in vitro diagnostics innovations at the 2014 AACC.

Siemens Unveils New Chemistry and Immunoassay Systems
Thursday, July 31, 2014
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

AB SCIEX Announces the 4500MD Series* for In Vitro Diagnostic Use
Tuesday, July 29, 2014
Industry leader increases mass spectrometry portfolio for clinical testing laboratories.

MDxI Launches LabFile Data Resource
Friday, July 25, 2014
New standard for defining and targeting US clinical laboratory universe.

New Paraffin Section Flotation Bath from Electrothermal
Thursday, July 24, 2014
New bath updates Electrothermal’s extensive histology range.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 470
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv